NBIX vs SCNX · P/E 45, rev $1.77B vs rev $400.0K
Neurocrine Biosciences Inc (NBIX) versus Scienture Holdings, Inc. (SCNX) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Scienture Holdings, Inc. (SCNX) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SCNX revenue for 2026-06-30 was $400.0K. Net income was -$6.2M. SCNX currently screens at market cap $15.8M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SCNX currently screens at market cap $15.8M.
Not investment advice. Open the NBIX and SCNX stock pages for the full models.
Not investment advice.